Your browser is no longer supported. Please, upgrade your browser.
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E24.99 EPS (ttm)21.61 Insider Own0.10% Shs Outstand394.00M Perf Week1.46%
Market Cap209.79B Forward P/E27.32 EPS next Y19.76 Insider Trans-13.96% Shs Float392.22M Perf Month7.05%
Income8.60B PEG5.00 EPS next Q4.60 Inst Own89.90% Short Float0.76% Perf Quarter14.84%
Sales38.25B P/S5.48 EPS this Y73.80% Inst Trans0.17% Short Ratio1.84 Perf Half Y5.95%
Book/sh88.98 P/B6.07 EPS next Y-10.72% ROA9.80% Target Price550.55 Perf Year31.53%
Cash/sh14.68 P/C36.78 EPS next 5Y5.00% ROE19.40% 52W Range401.07 - 543.30 Perf YTD15.94%
Dividend1.04 P/FCF32.38 EPS past 5Y26.50% ROI12.30% 52W High-1.76% Beta0.76
Dividend %0.19% Quick Ratio1.90 Sales past 5Y13.70% Gross Margin51.70% 52W Low33.08% ATR8.75
Employees80000 Current Ratio2.50 Sales Q/Q59.00% Oper. Margin20.40% RSI (14)64.50 Volatility1.72% 1.54%
OptionableYes Debt/Eq0.53 EPS Q/Q198.80% Profit Margin16.70% Rel Volume0.58 Prev Close540.01
ShortableYes LT Debt/Eq0.53 EarningsJul 28 BMO Payout5.30% Avg Volume1.63M Price533.72
Recom1.70 SMA202.25% SMA508.43% SMA20011.51% Volume792,434 Change-1.16%
Jul-16-21Initiated The Benchmark Company Buy $580
Mar-18-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21Initiated Barclays Overweight $525
Jan-08-21Upgrade Credit Suisse Neutral → Outperform $490 → $556
Dec-16-20Downgrade Citigroup Buy → Neutral $550 → $500
Dec-02-20Initiated Goldman Buy $570
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $550
Sep-30-20Initiated Atlantic Equities Overweight $494
Sep-14-20Initiated Morgan Stanley Overweight $485
Aug-20-20Resumed JP Morgan Overweight $460
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jul-07-20Reiterated Needham Buy $383 → $415
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
Jan-08-20Initiated Wells Fargo Equal Weight $350
Jan-07-20Initiated Citigroup Buy $380
Nov-15-19Initiated Stifel Buy
Jul-25-19Reiterated Needham Buy $315 → $321
Jul-16-19Downgrade Needham Strong Buy → Buy $315
Aug-02-21 09:27AM  
Jul-29-21 07:55AM  
Jul-28-21 08:31PM  
10:15AM  
07:15AM  
06:53AM  
06:24AM  
Jul-27-21 10:53AM  
06:00AM  
Jul-23-21 08:08AM  
Jul-22-21 11:10AM  
Jul-21-21 03:02PM  
Jul-20-21 05:50PM  
12:10PM  
Jul-19-21 06:04AM  
Jul-16-21 08:39AM  
Jul-15-21 08:00AM  
Jul-14-21 09:23AM  
07:51AM  
Jul-13-21 07:00AM  
Jul-12-21 08:15AM  
Jul-08-21 05:00PM  
07:51AM  
Jul-07-21 04:00PM  
09:00AM  
08:22AM  
08:00AM  
Jul-06-21 02:48PM  
Jun-29-21 07:59AM  
Jun-25-21 09:15AM  
Jun-23-21 10:15AM  
08:30AM  
Jun-22-21 12:00PM  
Jun-21-21 08:30AM  
Jun-14-21 02:36PM  
Jun-10-21 04:01PM  
Jun-08-21 04:12PM  
11:04AM  
07:38AM  
06:42AM  
Jun-07-21 01:38PM  
07:46AM  
Jun-03-21 05:50PM  
10:46AM  
Jun-02-21 02:01PM  
10:01AM  
08:26AM  
06:51AM  
Jun-01-21 04:43PM  
04:13PM  
May-28-21 09:10AM  
May-27-21 04:55PM  
09:15AM  
08:30AM  
May-20-21 11:32AM  
09:05AM  
May-19-21 05:00PM  
09:00AM  
May-12-21 07:00AM  
May-10-21 04:05PM  
May-07-21 01:20PM  
01:18PM  
11:00AM  
10:21AM  
May-06-21 06:38AM  
May-05-21 02:02PM  
Apr-30-21 01:31AM  
Apr-29-21 06:30AM  
06:29AM  
06:25AM  
06:00AM  
Apr-28-21 12:10PM  
09:13AM  
08:40AM  
Apr-27-21 07:07AM  
Apr-26-21 10:21AM  
Apr-22-21 12:48PM  
12:33PM  
08:04AM  
Apr-21-21 09:31AM  
Apr-19-21 08:37AM  
Apr-16-21 12:48PM  
12:14PM  
09:37AM  
09:19AM  
08:09AM  
07:53AM  
Apr-15-21 05:25PM  
04:47PM  
03:14PM  
03:04PM  
01:38PM  
11:52AM  
07:23AM  
07:17AM  
07:00AM  
03:17AM  
01:30AM  
Apr-14-21 04:28PM  
11:23AM  
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lagarde MichelExecutive Vice PresidentMay 10Option Exercise190.5921,6004,116,74440,061May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 10Sale464.5121,60010,033,51818,461May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 07Option Exercise190.5929,1005,546,16952,629May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 07Sale472.6034,16816,147,63618,461May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentFeb 12Sale507.797,2903,701,78915,775Feb 17 04:01 PM
Stevenson MarkExecutive Vice President & COODec 07Option Exercise129.7723,8253,091,77067,717Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 07Sale473.8414,1336,696,78153,584Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 04Option Exercise129.7723,8253,091,77058,005Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 04Sale476.4614,1136,724,28043,892Dec 08 04:31 PM
CASPER MARC NChairman & CEONov 02Sale484.0915,0007,261,35054,330Nov 04 04:09 PM
CASPER MARC NChairman & CEOOct 27Sale487.8310,0004,878,287211,594Oct 28 05:18 PM
CASPER MARC NChairman & CEOOct 26Sale479.9410,0004,799,386221,594Oct 28 05:18 PM
Stevenson MarkExecutive Vice President & COOAug 25Option Exercise131.0722,0002,883,54056,561Aug 27 04:22 PM
Stevenson MarkExecutive Vice President & COOAug 25Sale420.1622,0009,243,52034,561Aug 27 04:22 PM
Stevenson MarkExecutive Vice President & COOAug 24Option Exercise131.0722,0002,883,54070,621Aug 25 04:04 PM
Stevenson MarkExecutive Vice President & COOAug 24Sale429.5522,0009,450,10048,621Aug 25 04:04 PM
HORNSTRA PETER EVP & Chief Accounting OfficerAug 18Option Exercise136.503,337455,51219,862Aug 19 04:20 PM
HORNSTRA PETER EVP & Chief Accounting OfficerAug 18Sale418.823,3371,397,61918,212Aug 19 04:20 PM